Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.
about
Meta-analysis of microarray-derived data from PACAP-deficient adrenal gland in vivo and PACAP-treated chromaffin cells identifies distinct classes of PACAP-regulated genes.Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapiesPituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6.Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysis.Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neuronsAge-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophenImpaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1.PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury.Stereotactic coordinates for intracerebroventricular infusion after permanent focal cerebral ischemia in Wistar rats.PACAP38 protects rat cortical neurons against the neurotoxicity evoked by sodium nitroprusside and thrombin.Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice.Pharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion.PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosisPassage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress responsePACAP is an endogenous protective factor-insights from PACAP-deficient mice.Effect of PACAP in central and peripheral nerve injuries.Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation.Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats.Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements.PACAP38 suppresses cortical damage in mice with traumatic brain injury by enhancing antioxidant activity.Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.Protective effects of PACAP in ischemia.Review on PACAP-Induced Transcriptomic and Proteomic Changes in Neuronal Development and Repair.PACAP38 and PAC receptor blockade: a new target for headache?
P2860
Q31119681-7DB2B9D3-7362-49EC-9538-0C7B593FA0E3Q33624771-DAE146AB-448C-44C0-8E6B-FD7800EDB461Q34624638-D93900BC-D6A1-4052-968B-99F9EDEC6E35Q35124417-A9A366C4-92EC-4262-AADC-2FAC43FA8470Q35295564-C791E03C-4647-4B03-89FA-95CFFEF0BCA3Q35667237-5654CDD2-EB7A-457F-95E1-B7EAA428B0B5Q36354157-DE78517F-4ADC-408B-BAE6-644842A85BF8Q36464494-2104A7EF-443D-4559-B4CF-ECCD99BC2D82Q36569944-60C384AA-ECC3-4E40-9BB7-EC3C4FEBC28AQ36942673-715AE322-E7D5-4732-B6E4-E8C41BB0727CQ36955913-D25CEFD8-342D-4A39-B2A7-DE2739A62844Q37082670-3656EAD2-66C1-4219-A85B-043301DA248EQ37092303-DB32D4D3-31C6-42BB-9FE0-336D3F0B2CA0Q37294179-88C1F892-C064-4B65-930D-0A8044AA7947Q37578160-0FFD1F14-BFA7-43C9-A4B5-FF20952B8B2BQ37640081-9A1FD8E3-5858-4184-9B8D-D3B5B132A689Q37729367-5DE4A6E4-A104-4DC8-8861-36AA26B2B84BQ37851163-BB81E9CE-BDA7-43F4-ACD3-B49623C6BC3FQ38005003-69FF48B9-1947-4440-8B45-BAC3FCA6D24CQ38040105-C647B754-CEE7-40E4-AD45-C41B9E47A393Q39340625-17B57CB9-2429-4CE8-B333-4C9AAEA185CCQ39867396-44CF5390-2F93-4CF3-865B-A00C28DE131DQ43812646-C801C17F-6EC9-4B67-A878-89B4144BECAFQ43970109-25917E48-209A-4461-BBED-FBFEA0D6A944Q46882701-61ED99DC-FCBF-40A7-B9A1-9E6568912A9BQ48400890-FA196B57-CB7A-41DD-B7AE-3B7614565128Q48744942-486E0D04-A8C6-4E99-B996-073E1C4E0360Q52368754-EEA53AA2-9AC5-44D3-864C-64EA6D8B2712Q55021241-DA6873C9-6928-4E15-9CA3-24877B5FEF41Q58797905-321A1ABF-27CF-4D38-B1A1-7D8B1BB04890
P2860
Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of pretreatment with P ...... anent focal cerebral ischemia.
@en
Effects of pretreatment with P ...... anent focal cerebral ischemia.
@nl
type
label
Effects of pretreatment with P ...... anent focal cerebral ischemia.
@en
Effects of pretreatment with P ...... anent focal cerebral ischemia.
@nl
prefLabel
Effects of pretreatment with P ...... anent focal cerebral ischemia.
@en
Effects of pretreatment with P ...... anent focal cerebral ischemia.
@nl
P2093
P1433
P1476
Effects of pretreatment with P ...... anent focal cerebral ischemia.
@en
P2093
Lengvári I
Somogyvári-Vigh A
P304
P356
10.1016/S0196-9781(02)00262-0
P577
2002-12-01T00:00:00Z